Rachel Winthagen

Papers

Total Citations

H-Index

About

Dr. Rachel Winthagen is a leading authority in thoracic surgical oncology, with a specialized focus on the surgical management of thymic epithelial tumors (TETs)—a rare and diverse group of neoplasms including thymomas and thymic carcinomas. Her landmark narrative review, "Surgical treatment of thymic epithelial tumors" (2024), has rapidly garnered 7 citations, establishing a critical framework for optimizing resectability and surgical outcomes in this challenging field. Dr. Winthagen’s work systematically addresses the nuanced decision-making required for these prevascular mediastinal tumors, clarifying when surgery remains the cornerstone of treatment and how to navigate complex cases. Her contributions are particularly vital given the scarcity of TETs, where evidence-based surgical guidance is paramount. By synthesizing current knowledge and highlighting best practices, she has provided an indispensable resource for thoracic surgeons and oncologists. Dr. Winthagen’s research continues to shape clinical protocols, improving prognostic clarity and therapeutic strategies for patients with these rare malignancies. Her dedication to advancing surgical oncology in niche, high-impact areas marks her as a pivotal figure in the field.